Cyclo Therapeutics Inc (CYTH)
0.699
-0.01
(-1.38%)
USD |
NASDAQ |
Nov 21, 16:00
0.6978
0.00 (0.00%)
After-Hours: 20:00
Cyclo Therapeutics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 28, 2024 | 59.57 |
| June 27, 2024 | 56.29 |
| June 26, 2024 | 57.23 |
| June 25, 2024 | 54.88 |
| June 24, 2024 | 55.35 |
| June 21, 2024 | 60.98 |
| June 20, 2024 | 56.29 |
| June 18, 2024 | 54.88 |
| June 17, 2024 | 58.17 |
| June 14, 2024 | 56.29 |
| June 13, 2024 | 59.10 |
| June 12, 2024 | 60.04 |
| June 11, 2024 | 58.17 |
| June 10, 2024 | 58.64 |
| June 07, 2024 | 59.11 |
| June 06, 2024 | 58.64 |
| June 05, 2024 | 59.58 |
| June 04, 2024 | 60.51 |
| June 03, 2024 | 60.51 |
| May 31, 2024 | 60.04 |
| May 30, 2024 | 60.98 |
| May 29, 2024 | 60.51 |
| May 28, 2024 | 60.04 |
| May 24, 2024 | 63.33 |
| May 23, 2024 | 60.98 |
| Date | Value |
|---|---|
| May 22, 2024 | 60.51 |
| May 21, 2024 | 63.80 |
| May 20, 2024 | 66.61 |
| May 17, 2024 | 65.67 |
| May 16, 2024 | 64.27 |
| May 15, 2024 | 67.08 |
| May 14, 2024 | 66.14 |
| May 13, 2024 | 65.67 |
| May 10, 2024 | 68.96 |
| May 09, 2024 | 68.02 |
| May 08, 2024 | 70.36 |
| May 07, 2024 | 70.83 |
| May 06, 2024 | 71.77 |
| May 03, 2024 | 70.83 |
| May 02, 2024 | 68.95 |
| May 01, 2024 | 68.02 |
| April 30, 2024 | 68.49 |
| April 29, 2024 | 68.95 |
| April 26, 2024 | 59.10 |
| April 25, 2024 | 60.51 |
| April 24, 2024 | 60.98 |
| April 23, 2024 | 56.76 |
| April 22, 2024 | 59.10 |
| April 19, 2024 | 54.41 |
| April 18, 2024 | 56.29 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.277
Minimum
May 20 2022
71.77
Maximum
May 06 2024
11.68
Average
4.524
Median
Price to Book Value Benchmarks
| Stryker Corp | 7.381 |
| Biogen Inc | 1.408 |
| Pfizer Inc | 1.543 |
| Pacira BioSciences Inc | 1.071 |
| Moderna Inc | 1.234 |
Price to Book Value Related Metrics
| PS Ratio | 21.69 |
| Price | 0.699 |
| Earnings Yield | -128.8% |
| Market Cap | 20.11M |